154 related articles for article (PubMed ID: 646971)
21. Oestrogen production and metabolism in peri-menopausal women.
Reed MJ; Beranek PA; James VH
Maturitas; 1986 Mar; 8(1):29-34. PubMed ID: 3084922
[TBL] [Abstract][Full Text] [Related]
22. Plasma concentrations of luteinizing hormone and follicle-stimulating hormone during anoestrus in ewes actively immunized against oestradiol-17 beta, oestrone or testosterone.
Martensz ND; Scaramuzzi RJ; Van Look PF
J Endocrinol; 1979 Jun; 81(3):261-9. PubMed ID: 572861
[TBL] [Abstract][Full Text] [Related]
23. Endocrine effects of GnRH analogue with low-dose hormone replacement therapy in women with endometriosis.
Howell R; Dowsett M; King N; Edmonds DK
Clin Endocrinol (Oxf); 1995 Nov; 43(5):609-15. PubMed ID: 8548946
[TBL] [Abstract][Full Text] [Related]
24. Serum prolactin, gonadotrophin and oestrogen levels in women receiving hormone replacement therapy.
Lind T; Cameron EH; Hunter WM
Br J Obstet Gynaecol; 1978 Feb; 85(2):138-41. PubMed ID: 626723
[TBL] [Abstract][Full Text] [Related]
25. Postmenopausal oestrogen replacement therapy with subcutaneous oestradiol implants.
Suhonen S; Sipinen S; Lähteenmäki P; Laine H; Rainio J; Arko H
Maturitas; 1993 Mar; 16(2):123-31. PubMed ID: 8483424
[TBL] [Abstract][Full Text] [Related]
26. Plasma oestrogens in postmenopausal women with endometrial cancer.
Nyholm HC; Nielsen AL; Lyndrup J; Dreisler A; Hagen C; Haug E
Br J Obstet Gynaecol; 1993 Dec; 100(12):1115-9. PubMed ID: 8297845
[TBL] [Abstract][Full Text] [Related]
27. Some effects of treatment with ethinyl oestradiol with or without polyoestradiol phosphate in patients with prostatic carcinoma.
Tomić R
Scand J Urol Nephrol; 1986; 20(3):193-6. PubMed ID: 3097813
[TBL] [Abstract][Full Text] [Related]
28. Plasma levels of oestrone and oestradiol-17beta in postmenopausal women.
Badawy SZ; Elliott LJ; Elbadawi A; Marshall LD
Br J Obstet Gynaecol; 1979 Jan; 86(1):56-63. PubMed ID: 760768
[TBL] [Abstract][Full Text] [Related]
29. Comparison of serum oestrogen concentrations in post-menopausal women taking oestrone sulphate and oestradiol.
Anderson AB; Sklovsky E; Sayers L; Steele PA; Turnbull AC
Br Med J; 1978 Jan; 1(6106):140-2. PubMed ID: 620226
[TBL] [Abstract][Full Text] [Related]
30. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
[TBL] [Abstract][Full Text] [Related]
31. Circulating gonadotrophins and urinary oestrogens in postmenopausal diabetic women.
Quinn MA; Ruffe H; Brown JB; Ennis G
Aust N Z J Obstet Gynaecol; 1981 Nov; 21(4):234-6. PubMed ID: 6803757
[TBL] [Abstract][Full Text] [Related]
32. The significance of oestriol in the management of the post-menopause.
Tzingounis VA; Aksu MF; Greenblatt RB
Acta Endocrinol Suppl (Copenh); 1980; 233():45-50. PubMed ID: 6773286
[TBL] [Abstract][Full Text] [Related]
33. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
[TBL] [Abstract][Full Text] [Related]
34. Endocrine studies in postmenopausal women during oral replacement therapy with unconjugated oestrogens.
Vasquez JM; Samaras CA; Nezhat C
Reproduccion; 1982; 6(2):49-59. PubMed ID: 6216132
[TBL] [Abstract][Full Text] [Related]
35. Oestrogens, gonadotropins and prolactin after intra-vaginal administration of oestriol in post-menopausal women.
Keller PJ; Riedmann R; Fischer M; Gerber C
Maturitas; 1981 Mar; 3(1):47-53. PubMed ID: 6789033
[TBL] [Abstract][Full Text] [Related]
36. Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women.
Kelly JJ; Rajkovic IA; O'Sullivan AJ; Sernia C; Ho KK
Clin Endocrinol (Oxf); 1993 Nov; 39(5):561-7. PubMed ID: 8252746
[TBL] [Abstract][Full Text] [Related]
37. Influence of thyrotropin-releasing hormone on the postmenopausal female.
Lee SG; Lundy LE; Kashef M; Dorn J
Obstet Gynecol; 1975 Jan; 45(1):25-6. PubMed ID: 803307
[TBL] [Abstract][Full Text] [Related]
38. Utility of follicle stimulating hormone (FSH), luteinizing hormone (LH), oestradiol and FSH:LH ratio in predicting reproductive age in normal women.
Kim YK; Wasser SK; Fujimoto VY; Klein NA; Moore DE; Soules MR
Hum Reprod; 1997 Jun; 12(6):1152-5. PubMed ID: 9221992
[TBL] [Abstract][Full Text] [Related]
39. Serum concentrations of oestrone, oestradiol and oestriol during various oestrogen treatments.
Rauramo L; Punnonen R; Grönroos M
Maturitas; 1981 Aug; 3(2):183-6. PubMed ID: 7289888
[TBL] [Abstract][Full Text] [Related]
40. Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
Ausmanas MK; Tan DA; Jaisamrarn U; Tian XW; Holinka CF
Climacteric; 2007 Oct; 10(5):427-37. PubMed ID: 17852146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
